Sign Up
Stories
Genethon Leverages AI for Gene Therapy
Share
Advancements in Gene Therapy for Primary...
Animal Genetics Market Set for $9.5 Bill...
BenevolentAI Unveils 2023 Results
Biosimulation Market Set for Significant...
Biotech Innovations Reshaping Industries
Biotech Market Surge: Revenue Forecast
Overview
API
Genethon, a non-profit gene therapy R&D organization, leverages AI to improve gene therapy vectors and bioproduction efficiency, aiming to lower production costs and enhance patient access.
Ask a question
How might the widespread adoption of AI in gene therapy production impact the pharmaceutical industry and healthcare systems?
In what ways could the collaboration between Genethon and Whitelabs Genomics and Thales influence the future of gene therapy and bioproduction?
What are the potential ethical and regulatory implications of using AI in gene therapy development?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Aug 2023
Sep 2023
Oct 2023
Coverage